Allogene Therapeutics, Inc. (ALLO)
NASDAQ: ALLO · Real-Time Price · USD
2.080
-0.030 (-1.42%)
At close: Jul 2, 2026, 4:00 PM EDT
2.065
-0.015 (-0.71%)
After-hours: Jul 2, 2026, 7:19 PM EDT
Allogene Therapeutics Market Cap
Allogene Therapeutics has a market cap or net worth of $717.92 million as of July 2, 2026. Its market cap has increased by 152.48% in one year.
Market Cap
717.92M
Enterprise Value
532.09M
1-Year Change
152.48%
Ranking
Category
Stock Price
$2.08
Market Cap Chart
Since October 11, 2018, Allogene Therapeutics's market cap has decreased from $2.88B to $717.92M, a decrease of -75.08%. That is a compound annual growth rate of -16.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 717.92M | 133.18% |
| Dec 31, 2025 | 307.88M | -31.06% |
| Dec 31, 2024 | 446.60M | -17.32% |
| Dec 29, 2023 | 540.17M | -40.45% |
| Dec 30, 2022 | 907.08M | -57.34% |
| Dec 31, 2021 | 2.13B | -39.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 11, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Climb Bio | 760.99M |
| Aclaris Therapeutics | 745.80M |
| Aura Biosciences | 742.32M |
| Candel Therapeutics | 723.91M |
| SL Science Holding | 719.23M |
| Rigel Pharmaceuticals | 708.44M |
| Bright Minds Biosciences | 704.76M |
| Prime Medicine | 702.60M |